Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuraxis (NRXS) EBITDA Margin (2022 - 2025)

Historic EBITDA Margin for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to 258.82%.

  • Neuraxis' EBITDA Margin fell 111100.0% to 258.82% in Q3 2025 from the same period last year, while for Sep 2025 it was 225.43%, marking a year-over-year increase of 723200.0%. This contributed to the annual value of 266.46% for FY2024, which is 44500.0% up from last year.
  • Latest data reveals that Neuraxis reported EBITDA Margin of 258.82% as of Q3 2025, which was down 111100.0% from 192.14% recorded in Q2 2025.
  • Over the past 5 years, Neuraxis' EBITDA Margin peaked at 98.1% during Q2 2022, and registered a low of 633.0% during Q3 2023.
  • Its 4-year average for EBITDA Margin is 247.71%, with a median of 221.07% in 2022.
  • Per our database at Business Quant, Neuraxis' EBITDA Margin plummeted by -4385800bps in 2023 and then skyrocketed by 3853000bps in 2024.
  • Over the past 4 years, Neuraxis' EBITDA Margin (Quarter) stood at 160.86% in 2022, then crashed by -90bps to 305.42% in 2023, then skyrocketed by 37bps to 192.68% in 2024, then plummeted by -34bps to 258.82% in 2025.
  • Its EBITDA Margin was 258.82% in Q3 2025, compared to 192.14% in Q2 2025 and 256.25% in Q1 2025.